UNC seeks $125M to discover new drugs against future pandemic Date Published: April 10, 2020 CHAPEL HILL — UNC-Chapel Hill scientists are determined that the country doesn’t live through another pandemic anytime soon. Enter READDI…
Grifols pursues development of coronavirus treatment based on blood plasma Date Published: April 9, 2020 RESEARCH TRIANGLE PARK – Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, will produce and…
NCSU uses 3D printing tech to produce 200 face shields a day for WakeMed Date Published: April 8, 2020 RALEIGH – North Carolina State University remains committed to assisting the health care workers who are on the front lines…
$5M in loans available to small businesses from Mecklenburg County; Wake, Durham looking into idea Date Published: April 8, 2020 RALEIGH – Mecklenburg County is teaming with the Carolina Small Business Development Fund to offer $5 million in loans to…
UNC’s Entrepreneurship Center offers online series on how to navigate the ‘great pause’ of COVID-19 Date Published: April 8, 2020 CHAPEL HILL — Some are calling it the “great pause” — this period of sheltering in place for most Americans…
How Johnson Automotive is dealing with COVID-19 to keep customers safe Date Published: April 8, 2020 Editor’s note: This overview of how Johnson Automotive is dealing with the coronavirus pandemic by WRAL TechWire Board Member Erick …
Orthus Health offers diabetes management platform for free to clients during virus crisis Date Published: April 7, 2020 RALEIGH – Orthus Health is offering its diabetes management platform free of charge to its more than 100 clients to…
Raleigh pharma’s potential COVID-19 treatment to be used in Italy Date Published: April 7, 2020 A Triangle pharmaceutical organization has received special approval from the Italian government for use of its drug in the fight…
Gilead turbocharges production of COVID-19 hopeful remdesivir Date Published: April 6, 2020 Gilead Sciences’ remdesivir has courted high hopes as a potential treatment for COVID-19—so high, in fact, that the company previously…